Trial Number
418-23
Conditions
Leukemia, Lymphoma
Participant Age Range
15 years to 40 years
Participant Gender
Any
Enrolling Participants
No
Overview
“A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy”
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma.
Provider
Jacqueline N Casillas, MD
Hematology-Oncology - Pediatric, Pediatric Hematology/Oncology
Jacqueline N Casillas, MD
Hematology-Oncology - Pediatric, Pediatric Hematology/Oncology
